Other effects related to TLR signaling in NAFLD are the activation of ROS-forming mechanisms that favor the release of plasminogen activator inhibitor-1 (PAI-1) in the liver and the development of insulin resistance [169]. Here, SERPINE1 is linked to metabolic dysfunction-associated steatotic liver disease.